TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
YDES

YD Bio Ltd

Healthcare · Biotechnology

8.10$ +3.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet YDES
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q4 25 Q2 26
– +2.0% -20.8% +0.7% -36.3% -48.8% -16.1% +366.9% -27.0%
– -10.5% +30.7% -38.0% +1,696.2% -93.3% -17.8% +4,934.4% -42.2%
– +6.1% +790.8% -100.0% +156,614,800.0% -100.0% +1,466.3% +95,077.7% -55.7%
– +6.1% +790.8% -100.0% +156,614,800.0% -100.0% +1,466.3% +95,077.7% -55.7%
– +0.0% +188.7% +0.0% +387.5% -79.5% +0.0% +1,221.3% -21.5%
– – – – – – – +403.2% +0.7%
– – – – – – – -10.1% -5.2%
– +216.8% -51.6% -13.4% -98.0% +6,017.8% +13.4% -12.5% -66.4%
– +14.2% +7.3% +1.9% -97.4% +4,019.9% +3.5% -85.3% -35.0%
– – – – – – – – -26.0%
– – – – – – – +491.0% -10.1%
– -742.3% – – – -301.0% – – –
– – – – – – – – –
– +0.0% -1.8% -4.4% +0.0% -15.2% -0.3% +1,968.4% +0.5%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?